Results 151 to 160 of about 13,265 (210)

Characterization of a Long-Acting Anti-Human MASP-2 Antibody for the Treatment of Complement-Related Diseases. [PDF]

J Inflamm Res
Han X, Yang C, Wang Z, Fan K, Liu K, Ye H, Zhang W, Zhang J, Hu X, Lin H, Liao C.   +10 more
europepmc   +1 more source

Study on the Predictive Value of MASP-1 Combined with Four Thrombotic Molecular Markers for Disseminated Intravascular Coagulation in Patients with Severe Infection. [PDF]

Infect Drug Resist
Chang P, Sun M, Song H, Yang S, Wang Z, Chen L, Wang X.   +6 more
europepmc   +1 more source

Innate Immunity in the Cottonmouth Watersnake (<i>Agkistrodon piscivorus</i>). [PDF]

Animals (Basel)
Merchant M, Epperson J, Baker S.
europepmc   +1 more source

Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin Pathway Activation.

Structure, 2017
Nan R, Furze CM, Wright DW, Gor J, Wallis R, Perkins SJ.   +5 more
europepmc   +1 more source

Complement system activation is associated with spinal radiographic progression in axial spondyloarthritis after 2 years of follow-up: findings from the CONSUL RCT. [PDF]

RMD Open
Mistegaard C, Troldborg A, Torgutalp M, Loft AG, Thiel S, Muche B, Rios Rodriguez V, Protopopov M, Listing J, Sieper J, Poddubnyy D, Proft F.   +11 more
europepmc   +1 more source

Mannose Derivatives as Anti-Infective Agents. [PDF]

Int J Mol Sci
Ribić R.
europepmc   +1 more source

Targeting the lectin pathway in TA-TMA. [PDF]

Blood Adv
Jodele S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Quantification of mannan-binding lectin

Journal of Immunological Methods, 2006
Mannan-binding lectin (MBL) is attracting considerable interest due to its role in the immune defense. The high frequency of congenital MBL deficiency makes it feasible to evaluate clinical relevance through epidemiological investigations on fairly limited numbers of patients.
Frederiksen, Pernille D, Thiel, Steffen, Jensen, Lisbeth, Hansen, Annette G, Matthiesen, Finn, Jensenius, Jens Christian   +5 more
openaire   +3 more sources

Mannan-binding lectin in malignancy

Molecular Immunology, 2013
Complement may play a dual role in cancer: it may contribute either to the development or to the inhibition of tumour growth. Its components may be candidate biomarkers facilitating the disease detection, its progress or effectiveness of therapy. Additionally, complement deficiencies may increase the risk of infections and contribute to the higher ...
Anna S, Swierzko, David C, Kilpatrick, Maciej, Cedzynski   +2 more
openaire   +2 more sources

Mannan-Binding Lectin and Mannan-Binding Lectin-Associated Serine Protease 2 in Acute Pancreatitis

Pancreas, 2011
Complement activation may play a prominent role in acute pancreatitis (AP). Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) participate in complement activation. The objective of the present study was to evaluate the role of MBL and MASP-2 as markers in AP with regard to etiology, inflammatory activity, severity, and ...
Novovic, Srdan, Andersen, Anders Møller, Ersbøll, Annette Kjær, Jorgensen, Lars N, Nielsen, Hans J, Jensenius, Jens Christian, Hansen, Mark Berner   +6 more
openaire   +5 more sources